Short Interest in Aclarion, Inc. (NASDAQ:ACONW) Increases By 66.9%

Aclarion, Inc. (NASDAQ:ACONWGet Free Report) was the target of a significant growth in short interest during the month of August. As of August 14th, there was short interest totaling 231,797 shares, a growth of 66.9% from the July 30th total of 138,906 shares. Based on an average trading volume of 54,550 shares, the short-interest ratio is currently 4.2 days.

Aclarion Trading Up 11.0%

Shares of NASDAQ:ACONW opened at $0.03 on Monday. The company’s fifty day moving average is $0.03 and its 200 day moving average is $0.03. Aclarion has a 52 week low of $0.02 and a 52 week high of $0.23.

About Aclarion

(Get Free Report)

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.

Recommended Stories

Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.